Bullboard - Stock Discussion Forum Longeveron Inc LGVN

Healthcare Biotechnology

Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy... see more

Add To Watchlist

NDAQ:LGVN - Post Discussion

Longeveron Inc > Longeveron® Announces U.S. FDA Grants Fast Track Design

View:

Post by whytestocks on Jul 17, 2024 10:17am

Longeveron® Announces U.S. FDA Grants Fast Track Design

News; $LGVN Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B(TM) for the Treatment of Mild Alzheimer's Disease– FDA designation enables expedited clinical development and regulatory review timelines for Lomecel-B™ – – Second designation received for Lomecel-B™ for the treatment of mild Alzheimer’s Disease after Regenerative Medicine Advanced Thera...LGVN - Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B(TM) for the Treatment of Mild Alzheimer's Disease